ライフサイエンスコーパス: score of

1 he 45 patients achieved and maintained a VAS score of 0 during the 3-year observation period.

2 of a spatial competition index [SCI], with a score of 0 indicating weakest competition and 1 indicati

3 ophy, and vascular disease; specimens with a score of 0 or 1 (scale, 0-3) for each parameter were con

4 patients achieving PASI 75 and PGA response (score of 0 or 1 with >/=2 grade score reduction from bas

5 s defined as complete (final cutaneous ePOST score of 0 or 1) or partial response (ePOST drop >/=2 po

6 llent outcome (i.e., a modified Rankin scale score of 0 or 1).

7 nical Excellence registry (2008-2014) CHADS2 score of 0 or 1, we calculated the impact of adoption of

8 ooperative Oncology Group performance status score of 0 or 1; a normal left ventricular ejection frac

9 n criteria included a GOG performance status score of 0 or 1; adequate renal, hepatic, and bone marro

10 orable odds ratio of a modified Rankin scale score of 0 to 1 versus 2 to 6 compared with alteplase-tr

11 A Dean scale score of 0 to 2 (</=50% hair loss) was defined as treatm

12 s without; P < .001) and a low clinical risk score of 0 to 2 points (89 months with HAI v 53 months w

13 inutes (aRR, 1.34; 95% CI, 1.03-1.76), Apgar score of 0 to 3 at 5 minutes (aRR, 2.42; 95% CI, 1.62-3.

14 rrence risk ranging from less than 3% with a score of 0 to greater than 75% with a score of 5 or high

15 hin 3 years increased from 1.6% with RETREAT score of 0% to 29% for a score >/=5 (P < .001).

16 ) and the rate of functional independence (a score of 0, 1, or 2 on the modified Rankin scale, which

17 f abnormal tests, compared with those with a score of 0, global CVD risk was increased among particip

18 f Severity of 0 in CD or Mayo endoscopic sub-score of 0-1 for patients with UC.

19 an Eastern Cooperative Oncology Group (ECOG) score of 0-2 and a documented life expectancy of at leas

20 nce defined by a modified Rankin Scale (mRS) score of 0-2 at day 90.

21 tly associated with both a good outcome (mRS score of 0-2 at discharge; P = .02) and a 1-point decrea

22 nctional independence (modified Rankin Scale score of 0-2) and mortality at 90 days, symptomatic intr

23 Hair loss of 50% or less (Dean score of 0-2) was seen in 67 of 101 patients (66.3%; 95%

24 stern Cooperative Oncology Group performance score of 0-2.

25 dmission, defined by a modified Rankin Scale score of 0-2.

26 ore the next assessment than patients with a score of 0.

27 3663 s, along with an excellent selectivity score of 0.006 and an outstanding potency of 1.0 nM.

28 Children of mothers given MMN had a mean score of 0.11 SD (95% CI 0.01-0.20, p=0.0319) higher in

29 nff criteria for AMR; n = 65) yielded an AMR score of 0.19 +/- 0.15, intermediate between scores for

30 n groups showed absolute reductions in BMI z score of 0.20 or more and maintained their baseline weig

31 complex sample had a median precursor purity score of 0.46 for the 64,498 XCMS determined features, i

32 95% CI, 0.11-0.36) and for the MetS severity score of 0.50 (95% CI, -0.05 to 0.99).

33 improved linear growth by a length-for-age z score of 0.63.We aimed to test the efficacy of eggs intr

34 spectrally complex sample that had a purity score of 0.66 for 5071 XCMS features.

35 d ADCmax values was substantial, with an ICC score of 0.751 and 0.774, respectively (95% CI).

36 forest classifier our approach achieves an F-score of 0.87 across the ADRs classification using only

37 testing, and with Zubrod performance status scores of 0 or 1.

38 pants (Clinical Dementia Rating Scale global scores of 0) participating in the Harvard Aging Brain St

39 day modified Rankin Scale score (range, 0-6; scores of 0-2 indicate a good outcome).

40 er rates of independent outcomes (90-day mRS scores of 0-2, 25% vs 0%; P = .04), and smaller final in

41 Our approach achieves F-scores of 0.76 and 0.88 based on the BioNLP-ST and Genia

42 was associated with a decrease in cognitive score of -0.3 (-0.5, -0.1) standard deviations.

43 risk was increased among participants with a score of 1 (adjusted hazard ratio, 1.9; 95% CI, 1.4-2.6)

44 A cerebral performance category score of 1 (mild or no neurological deficit) or 2 (moder

45 with a Cerebral Performance Categories (CPC) score of 1 or 2 used to define favorable outcome.

46 Thirty-eight kidneys had an EVKP score of 1 or 2, 8 a score of 3 and 10 a score of 4 or 5

47 , Little Schmidy index (LS4) using a cut-off score of 1 to indicate fall risk with sensitivity of 79%

48 At age 13 years, a BMI z score of 1 was associated with hazard ratios (HRs) of 1.

49 psoriatic-like plaques in C57BL/6 mice (PASI score of 1) compared to imiquimod-only treatment (PASI s

50 with perfect intra-observer agreement (kappa score of 1).

51 clinically important difference in NRS pain score of 1.3.

52 YTP (amino acids: 1110 to 1119) with VaxiJen score of 1.3719 and 1.2215, respectively were used.

53 At month 2, vitreous haze was reduced from a score of 1.5+ to 0.5+ and 0 and BCVA improved by >/=3 li

54 nticoagulating AF patients with CHA2DS2-VASc scores of 1 or 2.

55 Scores of 1 to 3 indicate that revascularization is cons

56 tensive strategy, with a common OR for lower scores of 1.86 (95% CI, 1.22 to 2.83; P = .003).

57 Newborns had a mean length-for-age z score of -1.3 +/- 1.2 and 22% were stunted at birth.

58 me-wide association study for a genetic risk score of 10 VTE-associated variants.

59 48) of 110 patients with a combined positive score of 10% or more had a centrally assessed objective

60 rity number of at least 7 (out of a possible score of 10).

61 A CAC score of 100 or more had an incidence of 22.4 deaths per

62 A CAC score of 100 or more was associated with early death.

63 of the 13 deaths in participants with a CAC score of 100 or more, 10 were adjudicated as CHD events.

64 corticosteroids included baseline total Mayo score of 11 or higher (2.59, 0.93-7.21; p=0.068 [retaine

65 s generally high (mean score, 9 of a maximum score of 11) but the quality of the meta-analyzed studie

66 1 year, defined as a Dry Eye Questionnaire 5 score of 12 or more.

67 ol Use Disorders Identification Test (AUDIT) score of 12-19 who were aged 18-65 years from ten primar

68 iology as defined by a triage-Revised Trauma Score of 12.

69 und that 41% had a score less than 13; 27% a score of 13 to 27.5, and 32% a score greater than 27.5.

70 genation Sequential Organ Failure Assessment scores of 14 or more survived, whereas 52% of those with

71 omatic CD was defined by a CD Activity Index score of 150 or more and symptomatic UC by a partial May

72 ian Model for End-Stage Liver Disease (MELD) score of 17 (interquartile range 13-21), the mortality r

73 andomly assigned, with a mean baseline HAM-D score of 19.8 (SD=3.8).

74 Nine patients improved, with a median mRS score of 2 (range, 0-6).

75 ified Medical Research Council dyspnea scale score of 2 [ie, he had to stop for breath when walking a

76 Diffuse ptc and ptc score of 2 or greater remained independently related to

77 nonsplenic injury with an Abbreviated Injury Score of 2 or greater were excluded.

78 The association of ptc score of 2 or greater with cg was slightly better than w

79 ore lower than 2 vs 24% for those with qSOFA score of 2 or higher (absolute difference, 21%; 95% CI,

80 Patients with a score of 2 or less had a much better 5-year disease-free

81 tion admitted to an ICU, an increase in SOFA score of 2 or more had greater prognostic accuracy for i

82 Patients with a CHA2DS2-VASc score of 2 or more or those who had previously experienc

83 points, 2 or more SIRS criteria, or a qSOFA score of 2 or more points for outcomes among patients wh

84 or more SIRS criteria, and 54.4% had a qSOFA score of 2 or more points.

85 1.6; 95% CI, 1.0-2.2), Charlson Comorbidity score of 2 or more vs less than 2 (OR, 1.5; 95% CI, 1.0-

86 In patients with a CHA2DS2-VASc score of 2 or more, patients discontinuing warfarin trea

87 or more and symptomatic UC by a partial Mayo score of 2 or more.

88 dependence (mRS score of 3-5), disabled (mRS score of 2-5), and mRS evaluated as a continuous score.

89 re of only 4.2 (1.3) and a 7-point checklist score of 2.0 (1.9), both in the range of benignity.

90 09 segregating expression outliers (median z score of 2.97), averaging 13.3 genes per individual.

91 roparesis cardinal symptom index-daily diary scores of 2.6 or more.

92 te the year before screening; an areal BMD T score of -2.5 or lower at the total hip, femoral neck, o

93 ts who achieved an asthma control test (ACT) score of 20 or greater or an increase in ACT score from

94 ne receptor expression (40%) and had a Ki-67 score of 20%.

95 by 2.56 points for patients with a baseline score of 20-25 (9.26 for olanzapine vs 6.70 for placebo;

96 and a baseline best-corrected visual acuity score of 20/100 or less in the study eye were enrolled i

97 rs with a mean Model End-Stage Liver Disease score of 22.6 +/- 9.8.

98 % (95% CI, 65%-84%) in older women with MMSE scores of 24 (1-year risk: 6% [95% CI, 4%-9%] to 24% [95

99 Physiology and Chronic Health Evaluation II score of 25 (19-31), and hemoglobin level of 10.0 (9.0-1

100 CI 0.11-0.60), by 4.74 points for a baseline score of 25-35 (14.25 vs 9.51; 0.58, 0.34-0.86), and by

101 at baseline (a Mini-Mental State Examination score of 26 or higher) with no history of neurological o

102 year, with a mean improvement in the KCCQ-OS score of 27.6 (95% CI, 27.3-27.9) points at 30 days and

103 0 points), improved, with the median FACT-BP score of 28 (points) before treatment increasing to a me

104 % (95% CI, 19%-34%) in younger men with MMSE scores of 29 to 76% (95% CI, 65%-84%) in older women wit

105 modified Thrombolysis in Cerebral Infarction score of 2b or 3 at the end of all endovascular procedur

106 and who had a median Clinical Frailty Scale score of 3 (3-5).

107 tate adenocarcinoma (three patients, Gleason score of 3 + 4; and three patients, Gleason score of 4 +

108 ght kidneys had an EVKP score of 1 or 2, 8 a score of 3 and 10 a score of 4 or 5.

109 bbreviated Injury Scale head-region severity score of 3 or greater) and a prehospital systolic pressu

110 iseases, Ninth Revision head region severity score of 3 or greater, and/or Abbreviated Injury Scale h

111 ative Anticholinergic Cognitive Burden (ACB) score of 3 or higher (PUM-ACB), any antipsychotic prescr

112 outcomes included functional dependence (mRS score of 3-5), disabled (mRS score of 2-5), and mRS eval

113 ath at 3 months (modified Rankin Scale [mRS] score of 3-6).

114 An OPRS score of 3.0 (scale of 1 [poor] to 5 [excellent]) indica

115 gularly bordered lesions received a mean VAS score of 3.67, corresponding to an excellent response on

116 surgery needs significantly better than PSR scores of 3 (odds ratio = 27.8; P <0.001) in multilevel,

117 th increased risk among patients with CPS+EG scores of 3 or greater (HR 1.94, 95% CI 1.04-3.63) or ma

118 Imaging Reporting and Data System (BI-RADS) scores of 3-5 were deemed eligible.

119 th PSR scores of 4 and 125 sextants with PSR scores of 3.

120 se with NSCLC-adenocarcinoma and Lung-molGPA scores of 3.5 to 4.0 had a median survival of nearly 4 y

121 itized candidates had a median waitlist MELD score of 31 (IQR 27-34) when the liver was exported.

122 otal cohort had a median improvement in PASI score of 33%, with use of topical therapy (60%), biologi

123 .34-0.86), and by 8.01 points for a baseline score of 35-60 (21.72 vs 13.71; 0.70, 0.31-1.23).

124 of 284 participants (53%) with a median CAC score of 35.8 (interquartile range, 9.3-145.8).

125 >/=35 who were transplanted at a median MELD score of 39 (interquartile range [IQR] 37-40) with 30-da

126 score of 3 + 4; and three patients, Gleason score of 4 + 5) was performed across 23 spatially distin

127 ignificantly between the treatment groups (a score of 4 for ETV-CPC and 2 for ventriculoperitoneal sh

128 VKP score of 1 or 2, 8 a score of 3 and 10 a score of 4 or 5.

129 as defined as a 90-day modified Rankin Scale score of 4 or greater (range, 0-6).

130 For patients with a Wells score of 4 or less, CDS alerts suggested d-dimer testing

131 n TZ, upgrading category 3 to 4 based on DWI score of 4 or modified DCE score of positive; in PZ or T

132 eatment with antipsychotic medication, and a score of 4 or more on at least one selected Positive and

133 ations (aRR, 1.75; 95% CI, 1.26-2.42), Apgar score of 4 to 6 at 5 minutes (aRR, 1.34; 95% CI, 1.03-1.

134 ed for stratification factors (baseline pain score of 4 to 6 v 7 to 10 and prior taxane use).

135 2.07; 95% confidence interval, 1.97-2.19 for score of 4 versus 0) and rhythm control strategy (odds r

136 ) compared to imiquimod-only treatment (PASI score of 4).

137 y score of 4.7 (1.6) and a 7-point checklist score of 4.4 (2.3), while dermoscopically SK-like melano

138 sample achieved a mean (SD) total dermoscopy score of 4.7 (1.6) and a 7-point checklist score of 4.4

139 sociated with an increase in the total ASQ-3 score of 4.88 (95% CI: 2.09, 7.68; P = 0.001).

140 le newborns are profoundly virilized (Prader score of 4/5), and both genders display significantly ad

141 s upgraded from category 3 to 4 based on DWI score of 4; 33.3%-57.1% for TZ lesions upgraded from cat

142 robing data identified 486 sextants with PSR scores of 4 and 125 sextants with PSR scores of 3.

143 37.6% of sextants with both pretreatment PSR scores of 4 and a pretreatment periodontal access surger

144 PSR scores of 4 identified untreated sextants with periodont

145 A higher percentage of sextants with PSR scores of 4 or 3 revealed periodontal access surgical ne

146 Pretreatment PSR index scores of 4 were a strong indicator of periodontal acces

147 n a Model for End-Stage Liver Disease (MELD) score of 40 or higher before transplantation.

148 iver transplant recipients who achieved MELD score of 40 or higher from April 21, 2002, to May 15, 20

149 rt Form Health Survey (SF-36) general health score of 48 or more (2101 [86%] of 2451 participants in

150 the Lake Louise Questionnaire Score using a score of 5 or greater as a reference standard.

151 were similar for VAS(O), AMS-C, and CFS vs a score of 5 or greater on the LLQS (positive LRs: range,

152 st 2 instruments (1858 participants) using a score of 5 or greater on the LLQS as a reference standar

153 with a score of 0 to greater than 75% with a score of 5 or higher.

154 16.2%) with this genotype had a CDI severity score of 5.

155 17q21.2 (NPL score of 6.20) and 7p22.2 (NPL score of 5.19).

156 ld-to-moderate psoriasis, with a median PASI score of 5.2 (interquartile range, 3.0-8.9).

157 different between stool samples with Bristol scores of 5, 6, and 7, between pediatric and adult sampl

158 ell death-ligand 1 (PD-L1) tumour proportion score of 50% or greater (PD-L1-positive).

159 nts) before treatment increasing to a median score of 55 at 1-week follow-up and 60 at 6-month and su

160 Compared with the mean baseline TRS score of 57.0 (SD 10.2), the mean score at 6 months decr

161 tis at US met the study criteria (468 with a score of 5a; 109 with a score of 5b).

162 criteria (468 with a score of 5a; 109 with a score of 5b).

163 ase-free survival compared to those having a score of 6 or higher (93.9% vs 38.5%; P < 0.001).

164 a Gravis-Activities of Daily Living (MG-ADL) score of 6 or more, Myasthenia Gravis Foundation of Amer

165 e of each finding, with the highest possible score of 6 points.

166 i were identified on chromosome 17q21.2 (NPL score of 6.20) and 7p22.2 (NPL score of 5.19).

167 A total of 331 patients with a mean STS score of 6.7 +/- 6.7 underwent TAVR.

168 sterone receptor expression, and had a Ki-67 score of 60%.

169 A) and meta-analysis studies to date using a score of 62 RA risk SNPs (p < 5 * 10(-8)) as instrumenta

170 Presence of prostate cancer having Gleason score of 7 or higher on prostate biopsy.

171 igen alone for detecting cancer with Gleason score of 7 or higher.

172 Patients with Caprini scores of 7 to 8 [odds ratio (OR) 0.60, 95% confidence i

173 Scores of 7 to 9 indicate that revascularization is cons

174 val at 12 months after cardiac arrest with a score of 70 or higher on the Vineland Adaptive Behavior

175 er than 3 years, had a Karnofsky Performance Score of 70 or higher, were able to have an MRI scan, an

176 derate disability was defined as a cognitive score of 70 to 84 and either GMFCS level 2, active seizu

177 er than 5 ng/mL; and a Karnofsky performance score of 70% or higher.

178 109 mL) and IIEF score (overall satisfaction score of 8 from a maximum of 10) were normal, showing no

179 A score of 8 or less predicts a 95% probability of safe di

180 Remission was defined as having a SIGH-ADS score of 8 or less.

181 tudies was low (mean score, 2.8 of a maximum score of 8).

182 al Institutes of Health Stroke Scale (NIHSS) score of 8-20 to treatment with intravenous multipotent

183 ients with mean Society of Thoracic Surgeons score of 8.9 +/- 6.8% underwent TMVR.

184 th computation, with increased mean (95% CI) scores of 8.0 (2.2, 13.8), 6.8 (1.9, 11.7), and 4.8 (0.6

185 rial Fibrillation Effects on Quality of Life score of 80 (interquartile range [IQR]: 62.5 to 92.6) ve

186 ins and achieved a normalized domain overlap score of 89.3% compared to experimental data, which is s

187 s evaluated by comparing the original RD-OGI Scores of 893 eyes with OGI that presented between 1999

188 aseline symptom from the following: pruritus score of 9 or more, eight or more flushes per week, Hami

189 with a slightly worse child quality of life (score of 90.2 for broad-spectrum antibiotics vs 91.5 for

190 7mAb-treated group had significantly reduced scores of acute tubular injury and acute tubular necrosi

191 the best single correlations with severity (Scoring of AD, or SCORAD) are detected not only in lesio

192 o precompute and compare the deleteriousness scores of all common SNPs in the human genome in 44 cell

193 fective proteins, including predicted impact scores, of all these strains compared with the reference

194 Polygenic risk for AF was derived using a score of approximately 1000 AF-associated single-nucleot

195 tion: a daytime or night-time asthma symptom score of at least 1 for at least 2 days, rescue short-ac

196 12 months, and a COPD Assessment Test total score of at least 10.

197 M-IV-defined major depressive disorder and a score of at least 15 on the Montgomery-Asberg Depression

198 884 patients (44.9%) had a DAPT score of at least 2, and 1086 (55.1%) had a score less t

199 o McMaster Universities Osteoarthritis Index score of at least 39, and radiographic evidence of OA of

200 Among the 257 patients who had a VABS-II score of at least 70 before cardiac arrest and who could

201 aluated among patients who had had a VABS-II score of at least 70 before the cardiac arrest.

202 tically stable for at least 3 months and had scores of at least 20 on the negative subscale of the Po

203 ent (baseline), with assessments by NPZ-3 (z score of averaged Trailmaking A and B tests and digit sy

204 ge competence by achieving a minimum overall score of Band 7 on the International English Language Te

205 The mean score of BOP (P <0.05) was statistically significantly h

206 The scores of colour blind (CB) participants and normal-sigh

207 e SQDES, and secondary outcomes were symptom score of DED and a clinical diagnosis of DED.

208 ; for hip fractures: 0.85 (0.81, 0.89) per z score of dietary pattern adherence].

209 nhibitor, significantly reduced the clinical scores of EAE and attenuated mechanical allodynia and th

210 cell lines noted above, the Total Functional Score of Enhancer Elements (TFSEE) identified key breast

211 lyses using predicted erythrocyte and plasma scores of EPA and DHA yielded slightly stronger inverse

212 vitro extravasation assays, robust and rapid scoring of extravascular cells, combined with high-resol

213 h baseline NEI VFQ-25 composite and subscale scores of general vision, near activities, role difficul

214 ants with duodenal histology who had a Marsh score of greater than 1 were discontinued before dosing.

215 mental Motor Scales (second edition; PDMS-2) score of greater than 10 points and an increase in homov

216 breast cancer and who had average joint pain score of >/= 4 out of 10 that developed or worsened sinc

217 nts, 6 to 17 years old, with a vitreous haze score of >/=1.5+ or cystoid macular edema (CME) of >300

218 Depression was defined by a PHQ-9 score of >/=10.

219 n but had any of the following: CHA2DS2-VASc score of >/=2, sleep apnea, or body mass index >30 kg/m(

220 vity Score (scores range from 0 to 7, with a score of >/=3 indicating active thyroid-associated ophth

221 nalysis loop in EoE patients defined an IGHE score of >/=37.5 for a patient subpopulation with increa

222 h the Lake Louise Questionnaire Score (LLQS; score of >/=5).

223 were rates of response (reduction in HRSD-24 score of >/=50% from baseline) and remission (HRSD-24 sc

224 ients with nonvalvular AF and a CHA2DS2-VASc score of >1 in the National Cardiovascular Data Registry

225 ree) and high perceived stress (defined as a score of >20 on a perceived stress scale) on asthma morb

226 M-scores of >3 were allocated to senior surgeons.

227 Staff attained median scores of >90% in checklist evaluations of practical ski

228 renal arteries yielded a mean neurofilament score of healthy nerves that was significantly lower in

229 Lung injury scoring of histological sections was significantly worse

230 Manual scoring of IHC images represents a logistical challenge,

231 her investigated their correlations with the scores of impulsivity or risky behaviors.

232 results suggest that traditional behavioral scoring of individual zebrafish performed in 2D may unde

233 ted with the neural transition frequency, IQ scores of individuals with ASD are instead predicted by

234 Histologic scores of inflammation and site-specific development of

235 was positively correlated with the histology scores of inflammatory bowel disease patients.

236 g genetic markers, imaging QTs, and clinical scores of interest.

237 tation phenotype (A Limit) had an FEV1/FVC z score of less than -1.64 but not A Trpg.

238 s defined as a forced vital capacity (FVC) z score of less than -1.64 or an increase in FVC of 10% of

239 nt magnetic resonance imaging (MRI) severity score of less than 10 (scale range, 0-34; higher scores

240 wound healing defined as a Southampton wound score of less than 2 at 30 days postoperatively.

241 than 6.8% and baseline SF-36 general health score of less than 48 (350 [14%] of 2451 participants in

242 igher worsening between RH and TCSC CTs to a score of less than 6 (making the patient less likely to

243 tebral fracture and a bone mineral density T score of less than or equal to -1.50.

244 genation Sequential Organ Failure Assessment scores of less than 11.

245 The rates of 1-year survival with a CPC score of </=2 were 5.4% (98 of 1,827) overall, and 20% (

246 gher remission (147 [64%] of 230 had a PHQ-9 score of <10 in the HAP plus EUC group vs 91 [39%] of 23

247 sion II and remission from depression (PHQ-9 score of <10) at 3 months in the intention-to-treat popu

248 A score of <3 is associated with a low risk of HD and HCC

249 Primary outcomes were remission (AUDIT score of <8) and mean daily alcohol consumed in the past

250 se severity was scored using the Lund-Mackay scores of maxillofacial computed tomography (CT) scans.

251 rmine individual cytokine importance using Z scores of mean fluorescence intensity for individual cyt

252 genation Sequential Organ Failure Assessment score of more than 11 (3.3 [1.3-8.3]), idiopathic cardio

253 review using data-capture forms and blinded scoring of neuroimaging.

254 n arbovirologist-epidemiologist, identifying scores of newly recognized viruses from throughout the w

255 Patients, whose symptom scores of nose and eye were 0 and 1 point without any re

256 K-like melanomas achieved a total dermoscopy score of only 4.2 (1.3) and a 7-point checklist score of

257 and OCT images were obtained along with Munk scores of patient epiphora.

258 Using the highest non-ICU score of patients, >/=2 SIRS had a sensitivity of 91% an

259 The scores of patients with Barrett's oesophagus seem to be

260 ypometabolism and hypermetabolism with motor scores of patients with early HD.

261 scores that were 6.15 points lower than the scores of patients with focal damage (beta = -6.15; 95%

262 an outlier, with a significantly lower mean score of PD-L1 expression in both tumor and immune cells

263 caused a number of recent outbreaks killing scores of people and causing significant losses in anima

264 Mean scores of PI (P <0.05) and PD >/=4 mm (P <0.05) were sta

265 ted with skin aging manifestation, including score of pigment spots on forehead (12.5% more spots per

266 evels were associated with total and general score of Positive and Negative Syndrome Scale, illness s

267 nencapsulated sheetlike enhancement) for DCE score of positive in TZ; and 56.4%-61.9% for lesions in

268 s upgraded from category 3 to 4 based on DCE score of positive when incorporating new criteria (unenc

269 to 4 based on DWI score of 4 or modified DCE score of positive; in PZ or TZ, upgrading category 4 to

270 tious diseases diagnostics must contend with scores of potential pathogens, dozens of clinical syndro

271 It interacts with scores of protein partners of diverse functional classes

272 According to ASUDAS, the scores of radicualr grooves were 56.74%, 16.85%, 12.36%,

273 average Digestible Indispensable Amino Acid Score of red lentils (0.54) was higher than green lentil

274 e Protein Digestibility-Corrected Amino Acid Score of red lentils (55.0) was higher than that of gree

275 s), and chlorophyll content and with highest scores of sensory attributes (also at 16days).

276 nt activity (also at 16days), but with least scores of sensory attributes.

277 ing the Arabic CAM-ICU ratings and the total score of SOFA (severity of illness) and MMSE (cognitive

278 demiologic Studies Depression Scale; a total score of ten or higher was used as a cutoff to indicate

279 the change in the Physical Component Summary score of the 36-Item Short-Form Health Survey.

280 The mean +/- SD score of the ACQ decreased from 1.39 +/- 0.91 at baselin

281 The total root-coverage esthetic score of the areas including treated and adjacent untrea

282 clinical hypothyroidism trial, the median IQ score of the children was 97 (95% confidence interval [C

283 atherosclerotic cardiovascular disease risk score of the cohort was 4.8% (interquartile range: 2.8%

284 a 2.5 points better mean physical component score of the SF-36 (95% CI 0.3-4.8; p=0.028).

285 associated with clinical improvement (motor score of the Unified Parkinson Disease Rating Scale [UPD

286 pectively 3 months prior to the stroke using scores of the 5-item International Index of Erectile Fun

287 s of axonal densities reflected the clinical scores of the chronic phase.

288 Compared to the placebo group, the scores of the National Institutes of Health Stroke Scale

289 a feasible Bayesian bound that uses quality scores of the reads to align them to a genome of referen

290 While DHA did not affect the duration or scores of the seizures induced by pentylenetetrazole, DH

291 Gait was assessed using clinical scoring of the beam-walking test and video-kinematic ana

292 Clinical scoring of the eyes was performed 24 and 48 hours after

293 ormation and enhanced interpretation through scoring of the portions of the tree most influenced by t

294 Accordingly, partial 'un-scoring' of the problematic phylogenetic characters was

295 the Fagerstrom Test for Nicotine Dependence score; of these, 11 SNPs remained significant after Bonf

296 ythrocyte congestion and improved histologic scores of tubular injury 4 days after IRI.

297 016, to compare antibodies and pathologists' scoring of tumor and immune cells.

298 compare the EEG/EMG-based and the WBP-based scoring of wake-sleep states of mice, and provide formal

299 Mean NDI-SF score of Whipple group was 23.1 (SD 8.88).

300 ent and 167 (88.4%) had a high embolism risk score, of whom 139 (83.2%) were also at low risk of comp